中国颅内动脉粥样硬化性疾病防治研究现况及对策

目的 基于文献计量学方法分析全球颅内动脉粥样硬化性疾病研究发展趋势,分析中国相关研究的现况及不足,探讨适宜的应对策略。 方法 检索SCI-Expanded数据库1900—2018年全球颅内动脉粥样硬化性疾病研究相关文献,采用Web of Science自带软件及Excel 2007等软件进行定量分析,指标包括文献量、被引频次、h指数、基金论文比、高贡献机构等;单独分析来源于中国的相关文献,并与美国、日本、德国进行比较。 结果 1900—2018年全球共产出与颅内动脉粥样硬化性疾病相关的文献8 468篇,总被引频次189 950次,篇均被引频次22.43,h-index为155。美国是全球颅内动脉粥样硬化性疾病研究的绝对主力,贡献了全球30.53%的论文产出以及43.81%的被引频次,论文整体的h-index也很高,达121。中国(不含中国台湾地区)相关论文产出整体呈上升趋势,总论文产出1 157篇,位列全球第二,从1991年第1篇论文发表,到2003年达14篇,再到2014年达105篇、2018年达189篇,呈现迅猛发展的势头,其中首都医科大学贡献最大,居全球论文产出机构排名第一。但中国相关论文研究质量仍较美国低,有待进一步提升。 结论 中国颅内动脉粥样硬化性疾病相关研究尽管起步较晚,但近年来取得了迅猛发展,在全球的影响力越来越大;然而高影响力论文仍较缺乏,未来需要进一步加强随机对照试验(randomized controlled trial,RCT)、病因学、影像诊断学及治疗学等热点研究,从数量提升转化为质量提升。 

Current situation and countermeasure of prevention and treatment of intracranial atherosclerotic diseases in China

Objective To analyzes the development trend of global research on intracranial atherosclerotic diseases based on the bibliometric method, analyzes the current situation and shortcomings of relevant research in China, and explores the appropriate coping strategies. Methods Relevant literatures of global research on intracranial atherosclerotic diseases from 1900 to 2018 in SCI expanded database were retrieved and quantitatively analyzed by the software of web of science, Excel 2007 and other software. The indicators included literature quantity, cited frequency, h-index, fund paper ratio, high contribution institutions, etc. Relevant literatures from China were separately analyzed and compared with those from the United States, Japan and Germany. Results There were 8 468 articles related to intracranial atherosclerotic diseases published in the world from 1900 to 2018, with a total citation frequency of 189 950, all of which were cited with a frequency of 22.43 and h-index 155. The output of related papers in China(excluding Taiwan, China) was on the rise as a whole. The total output of related papers was 1 157, ranking second in the world. In 1991, the first paper was published, reaching 14 in 2003, in 2014 it reached 105, in 2018 it reached 189, only 8 fewer than the United States, showing a momentum of rapid development. Among them, Capital Medical University had the largest contribution, ranking first in the global output of papers. However, the research quality of papers in China was still lower than that in the United States, which need to be further improved. Conclusion The research on intracranial atherosclerotic diseases in China starts late, but it has made rapid development in recent years. It has more and more influence in the world, and there is still a lack of high influence. In the future, it is necessary to further strengthen the hot research such as RCT, etiology, imaging diagnosis and treatment, from quantity improvement to quality improvement.